Table 1.
Characteristic | No. Screened | HCV Prevalence (%) | OR (95% CI) | Adjusted OR (95% CI) |
---|---|---|---|---|
Age | ||||
Non-Birth Cohort | 2246 | 2.8 | ||
Birth Cohorta | 435 | 29.2 | 14.5 (10.5–20.1) | 17.9 (12.0–26.8) |
Sex | ||||
Female | 1019 | 5.0 | ||
Male | 1660 | 8.3 | 1.7 (1.2–2.4) | 2.4 (1.5–3.6) |
Race/Ethnicity | ||||
Black | 2408 | 6.6 | ||
Non-Black | 273 | 11.4 | 1.8 (1.2–2.7) | 1.8 (1.3–2.4) |
HIV status | ||||
Negative | 2608 | 6.9 | ||
Positive | 73 | 11.0 | 1.7 (0.8–3.5) | 1.6 (0.6–4.1) |
MSM | ||||
No | 2509 | 7.3 | ||
Yes | 172 | 2.9 | 0.4 (0.2–0.9) | 0.3 (0.1–0.8) |
Ever IDU | ||||
No | 2524 | 2.3 | ||
Yes | 157 | 84.1 | 228.5 (138.4–377.4) | N/A |
Current IDU | ||||
No | 2633 | 5.8 | ||
Yes | 48 | 77.1 | 54.9 (27.5–109.8) | 76.1 (33.1–174.7) |
Non-IDU | ||||
No | 2566 | 5.9 | ||
Yes | 115 | 33.9 | 8.3 (5.4–12.6) | 3.4 (2.0–6.0) |
Hazardous alcohol consumptionb | ||||
No | 1968 | 7.9 | ||
Yes | 713 | 4.6 | 0.6 (0.4–0.8) | 0.6 (0.4–1.0) |
Insurance status | ||||
No | 1419 | 4.5 | ||
Yes | 1262 | 9.9 | 2.3 (1.7–3.2) | 1.8 (1.2–2.5) |
>2 sex partners in past 90 days/anonymous sex | ||||
No | 2112 | 7.2 | ||
Yes | 569 | 6.5 | 0.9 (0.6–1.3) | |
Prior STD diagnosis | ||||
No | 1521 | 6.8 | ||
Yes | 1160 | 7.4 | 1.1 (0.8–1.5) | |
STD diagnosis on date of HCV diagnosis | ||||
No | 2122 | 7.1 | ||
Yes | 559 | 6.8 | 1.0 (0.7–1.4) |
Birth cohort: Individuals born between 1945 and 1965, as defined by the CDC.
Hazardous alcohol consumption defined as reported use of ≥4 alcoholic drinks in 1 sitting or risky sex under the influence of alcohol in the preceding 30 days
Ever IDU not included in the multivariable analysis
Abbreviations used in the table:
Current IDU: Current (within past 12 months) injection drug use.
Non-IDU: Non injection drug use within the past 12 months.
HIV: Human Immunodeficiency Virus
MSM: Men who have Sex with Men
STD: Sexually Transmitted Disease
HCV: Hepatitis C Virus